Pablo Altman Selected Research

Pablo Altman Research Topics

13	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 04/2014
6	Asthma (Bronchial Asthma) 02/2023 - 09/2018
4	Inflammation (Inflammations) 12/2023 - 09/2018
2	Dyspnea (Shortness of Breath) 01/2017 - 08/2015
1	Airway Obstruction (Choking) 12/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2023
1	Cystic Fibrosis (Mucoviscidosis) 12/2023
1	Hypersensitivity (Allergy) 09/2022
1	Food Hypersensitivity (Food Allergy) 09/2022
1	Immediate Hypersensitivity 09/2022
1	Peanut Hypersensitivity (Peanut Allergy) 09/2022
1	Nasal Polyps (Nasal Polyp) 01/2022
1	Eosinophilia 01/2021

3	prostaglandin D2 receptorIBA 01/2022 - 09/2018
3	Prostaglandin D2IBA 01/2021 - 09/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020 - 12/2014
3	Tiotropium Bromide (Spiriva)FDA Link 01/2018 - 01/2015
3	Muscarinic AntagonistsIBA 01/2018 - 08/2015
3	Bronchodilator Agents (Bronchodilators)IBA 01/2017 - 09/2014
3	indacaterolIBA 01/2017 - 12/2014
2	SmokeIBA 12/2023 - 01/2023
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2023 - 01/2023
2	AllergensIBA 02/2023 - 09/2022
2	fevipiprantIBA 01/2022 - 01/2021
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2018 - 01/2015
1	CytokinesIBA 02/2023
1	tezepelumabIBA 02/2023
1	Thymic Stromal LymphopoietinIBA 02/2023
1	Monoclonal AntibodiesIBA 02/2023
1	Immunoglobulin FragmentsIBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	ligelizumabIBA 09/2022
1	Immunoglobulin E (IgE)IBA 09/2022
1	talizumab (TNX901)IBA 09/2022
1	anti-IgE antibodiesIBA 09/2022
1	IgE Receptors (Fc epsilon RI)IBA 09/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	LipidsIBA 09/2018
1	GoldIBA 08/2015
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2015
1	Salmeterol Xinafoate (Serevent)FDA Link 12/2014
1	Fluticasone (Cutivate)FDA LinkGeneric 12/2014

4	Therapeutics 02/2023 - 04/2014
4	Nebulizers and Vaporizers (Inhaler) 03/2020 - 01/2017
1	Biological Therapy 02/2023
1	Injections 03/2020
1	Respiratory Therapy (Therapy, Respiratory) 06/2018
1	Self Administration (Administration, Self) 06/2018
1	Dry Powder Inhalers 06/2018